We are live on ! Find out more
RECS icon

Columbia Research Enhanced Core ETF

6 hedge funds and large institutions have $20.7M invested in Columbia Research Enhanced Core ETF in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

20% more funds holding

Funds holding: 56 (+1)

10% more capital invested

Capital invested by funds: $18.8M → $20.7M (+$1.93M)

15.43% less ownership

Funds ownership: 79.39%63.96% (-15%)

Holders
6
Holders Change
+1
Holders Change %
+20%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
3
Reduced
2
Closed
Calls
Puts
Net Calls
Net Calls Change

RECS Hedge Fund Activity: Q1 2022 in Review

6 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Columbia Research Enhanced Core ETF (RECS) for Q1 2022, worth a combined $20.7M — up 10% from $18.8M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new RECS positions and 0 closed out — a net gain of 1 holder — while 3 added to existing stakes and 2 trimmed.

The largest buyer was Ameriprise, adding an estimated $1.72M. The largest seller was Fulcrum Equity Management, cutting an estimated $45.3K.

  • 6 institutional investors held Columbia Research Enhanced Core ETF (RECS) as of Q1 2022, up from 5 in Q4 2021.
  • Funds reported $20.7M of Columbia Research Enhanced Core ETF stock for Q1 2022, up 10% quarter-over-quarter.
  • 1 fund opened new Columbia Research Enhanced Core ETF positions in Q1 2022 and 0 closed out, a net change of +1 holder.
  • The largest Columbia Research Enhanced Core ETF buyer in Q1 2022 was Ameriprise, an estimated $1.72M added.
  • The largest Columbia Research Enhanced Core ETF seller in Q1 2022 was Fulcrum Equity Management, an estimated $45.3K sold.

Based on aggregated 13F filings for Q1 2022.